Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells in Drug Discovery 2015

Lorenz Mayr's Biography

Lorenz Mayr, Vice President, AstraZeneca Ltd

Lorenz is working as Vice President, Reagents & Assay Development with global responsibility for generation of biological reagents and assay development activities at AstraZeneca. This includes generation of proteins and cell lines for hit finding, hit-to-lead and lead optimisation activities including structure & biophysics for all therapeutic areas, generation of tool antibodies, transgenic animals, stem/primary cells as tools for target validation and lead optimisation. His department is responsible for the development of biochemical, cell-based and phenotypic assays at AstraZeneca.
Before that, he was working as Executive Director at Novartis in Basel/Switzerland, at Bayer in Leverkusen & Wuppertal/Germany and at the MIT/Whitehead Institute in Cambridge/MA (U.S.A.).
He has published more than 50 papers in peer-reviewed journals and serves on several editorial and scientific advisory boards, including two terms at the Board of Directors for SBS (2004-2011) and has been working as the Conference Chair of the MipTec Conference, Europe’s largest drug discovery event.

Lorenz Mayr Image

Stem Cells in Drug Discovery: Applications in Hit Discovery & Lead Optimisation

Tuesday, 2 June 2015 at 10:00

Add to Calendar ▼2015-06-02 10:00:002015-06-02 11:00:00Europe/LondonStem Cells in Drug Discovery: Applications in Hit Discovery and Lead OptimisationStem Cells in Drug Discovery 2015 in

The presentation will describe the use of cell lines derived from human induced pluripotent stem cells (iPSC) for target validation, hit discovery and safety assessment for various therapeutic areas within AstraZeneca.

Add to Calendar ▼2015-06-02 00:00:002015-06-03 00:00:00Europe/LondonStem Cells in Drug Discovery 2015Stem Cells in Drug Discovery 2015 in